ApoCell, Inc.   We are dedicated to personalized medicine and distinguished by our personalized service. Recognized as a leader in biomarker research, we focuse our efforts on the identification and analysis of biomarkers in rare circulating cells. We use both standard and proprietary platforms to isolate and enrich cell populations of interest, especially circulating tumor cells (CTCs) and circulating endothelial cells (CECs), as well as additional rare cell types including stem cells.